As evidenced in a DSS-induced colitis model, IPA protects lipopolysaccharide (LPS)-challenged mice by activating AhR to promote interleukin-10 (IL-10, an anti-inflammatory cytokine) production while suppressing gene expression of TNF-α, a proinflammatory cytokine [50]. The gene discussed is IL10; the disease is colitis.